JPMorgan Chase & Co’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111 | Hold |
34
| – | – | ﹤0.01% | 5936 |
|
|
2025
Q1 | $70 | Sell |
34
-19
| -36% | -$39 | ﹤0.01% | 6040 |
|
|
2024
Q4 | $117 | Buy |
53
+3
| +6% | +$7 | ﹤0.01% | 5934 |
|
|
2024
Q3 | $84 | Buy |
50
+16
| +47% | +$27 | ﹤0.01% | 5955 |
|
|
2024
Q2 | $83 | Sell |
34
-15
| -31% | -$37 | ﹤0.01% | 5898 |
|
|
2024
Q1 | $232 | Sell |
49
-1,632
| -97% | -$7.73K | ﹤0.01% | 5777 |
|
|
2023
Q4 | $7.73K | Buy |
1,681
+1,647
| +4,844% | +$7.58K | ﹤0.01% | 5449 |
|
|
2023
Q3 | $88 | Hold |
34
| – | – | ﹤0.01% | 5961 |
|
|
2023
Q2 | $164 | Hold |
34
| – | – | ﹤0.01% | 5742 |
|
|
2023
Q1 | $0 | Hold |
34
| – | – | ﹤0.01% | 6030 |
|
|
2022
Q4 | $0 | Sell |
34
-87,862
| -100% | – | ﹤0.01% | 5816 |
|
|
2022
Q3 | $650K | Buy |
87,896
+87,701
| +44,975% | +$649K | ﹤0.01% | 3596 |
|
|
2022
Q2 | $1K | Sell |
195
-500
| -72% | -$2.56K | ﹤0.01% | 5498 |
|
|
2022
Q1 | $17K | Buy |
695
+177
| +34% | +$4.33K | ﹤0.01% | 5296 |
|
|
2021
Q4 | $25K | Buy |
518
+497
| +2,367% | +$24K | ﹤0.01% | 5276 |
|
|
2021
Q3 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 5389 |
|